Cost-Effectiveness of Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation:: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network

BACKGROUND: The Cardiothoracic Surgical Trials Network (CTSN) recently reported no difference in left ventricular end-systolic volume index or in survival at 2-years between patients with severe ischemic mitral regurgitation (MR) randomized to mitral-valve repair or replacement. However, replacement...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Circ Cardiovasc Qual Outcomes
Главные авторы: Ferket, Bart S., Ailawadi, Gorav, Gelijns, Annetine C., Acker, Michael A., Hohmann, Samuel F., Chang, Helena L., Bouchard, Denis, Meltzer, David O., Michler, Robert E., Moquete, Ellen G., Voisine, Pierre, Mullen, John C., Lala, Anuradha, Mack, Michael J., Gillinov, A. Marc, Thourani, Vinod H., Miller, Marissa A., Gammie, James S., Parides, Michael K., Bagiella, Emilia, Smith, Robert L., Smith, Peter K., Hung, Judy W., Gupta, Lopa N., Rose, Eric A., O’Gara, Patrick T., Moskowitz, Alan J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6383805/
https://ncbi.nlm.nih.gov/pubmed/30785252
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы